PLOS Pathogens
Q1 Journal
Open Access
Journal
Country
United States
Northern America
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Genetics
Q1
└
Immunology
Q1
└
Microbiology
Q1
Publisher
SJR 2025
1.932
Q1
SJR Score
H-Index
274
Citations / Doc (2yr)
4.81
Total Docs. (latest)
744
Total Citations (3yr)
10,054
Publication type
Journals
ISSN
15537374, 15537366
Coverage
2005-2026
Journal Rank
#1,545
Subject Categories
Genetics
Q1
Immunology
Q1
Microbiology
Q1
Molecular Biology
Q1
Parasitology
Q1
Virology
Q1
Aims & Scope
Bacteria, fungi, parasites, prions and viruses cause a plethora of diseases that have important medical, agricultural, and economic consequences.
Moreover, the study of microbes continues to provide novel insights into such fundamental processes as the molecular basis of cellular and organismal function.
PLOS Pathogens reflects the full breadth of research in these areas by publishing outstanding original articles that significantly advance the understanding of pathogens and how they interact with their host organisms.
Topics include (but are not limited to) adaptive and innate immune defenses as well as pathogen countermeasures, emerging pathogens, evolution, genomics and gene regulation, model host organisms, pathogen-cell biology, pathogenesis, prions, proteomics and signal transduction, rational vaccine design, structural biology, and virulence factors.
The journal will not consider purely descriptive studies, such as those that solely identify a new genomic sequence of a related pathogen or a series of related pathogens, the isolation of pathogen variants, or a new strain or type based only on sequence analysis or correlative studies of host and pathogen genotypes.
Genomics studies, which include functional predictions or inferences based on genome sequence analysis, will also require additional experimental validation that directly tests the prediction/inference and yields novel conclusions about mechanistic models or pathogenesis.
Instances where inferences about potential functions can be supported by association studies of genotype-phenotype combined with existing functional data, may also be appropriate, pending approval by the editors.
If a paper provides novel mechanistic insight but lacks functional validation, it may be considered on a case-by-case basis.
Abstracting & Indexing
Scopus
Google Scholar
Directory of Open Access Journals (DOAJ)
Web of Science
Medline
PubMed
Embase
Detailed Metrics
| Total Docs. (latest) | 744 |
| Total Docs. (3 years) | 1,976 |
| Total Refs. | 49,911 |
| Total Citations (3 years) | 10,054 |
| Citable Docs. (3 years) | 1,965 |
| Citations / Doc. (2 years) | 4.81 |
| Ref. / Doc. | 67.08 |
| % Female | 44.9% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.